Modular RNA Synthesis Micro-Factory Flow System
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for a scalable and cost-effective method to rapidly synthesize RNA-based vaccines, particularly for urgent vaccine demands in low- and medium-income countries, that can be easily deployed and stored, while minimizing waste and resource consumption.
Innovation Solution
A modular and integrated micro-factory flow system combining a flow reactor unit, continuous filtration unit, and mixing unit, with optional analytical probes for in-situ control, using a fluid flow bioreactor module and filtration module interconnected via conduits, allowing for continuous and automated operation with electronic and software control, enabling the synthesis and filtration of RNA and other nucleic acid substances.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional batch manufacturing methods are used for RNA synthesis, then flexibility and ease of operation are maintained, but productivity and resource utilization are low
Solution Approach 1:
The manufacturing system is divided into separate modular units (mixing module, reaction module, filtration module, formulation module) that can be independently configured and operated. Each module performs a specific function in the RNA synthesis process, allowing for optimized performance while maintaining overall system flexibility.
Solution Approach 2:
The system employs dynamic flow control through programmable pumps and valves that can adjust reaction parameters in real-time. The continuous flow nature of the system allows dynamic optimization of residence times, mixing rates, and reagent delivery to maximize productivity.
2Productivity
If continuous flow system is implemented for RNA synthesis, then productivity and resource utilization improve, but device complexity increases
Solution Approach 1:
The modular modules are designed with universal interfaces and standardized connection protocols that allow them to be reused for different RNA synthesis protocols and applications. The same filtration module, for example, can serve multiple reaction modules, reducing overall system complexity.
Solution Approach 2:
The system incorporates automated monitoring and control features where sensors detect process parameters (pH, temperature, flow rates) and the control system automatically adjusts parameters to maintain optimal conditions, reducing the need for complex manual intervention and simplifying operation.
3Adaptability or versatility
If modular flow system is used for RNA synthesis, then scalability and flexibility are improved, but manufacturing precision and control difficulty increase
Solution Approach 1:
The system incorporates sensors throughout the modular modules that continuously monitor critical parameters such as pH, temperature, and reagent concentrations. This feedback is fed to the control system which automatically adjusts flow rates and reaction conditions to maintain precise control over the RNA synthesis process, ensuring consistent product quality across different scales.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This system enables rapid, scalable, and cost-effective synthesis of RNA-based vaccines at the point of use, improving productivity and reducing environmental impact and resource utilization, while allowing for real-time monitoring and control of the synthesis process.
Implementation Method 1
Flow reactors, alternatively termed continuous flow reactors, provide for a continuous flow of materials or reactants through a network of conduits connected to form a passage of fluid
Implementation Method 2
a filtration module having a fluid filtration region, an inlet and an outlet, the inlet in fluid communication with the outlet of the reactor module
Data Source
AI summary
A method of RNA synthesis via fluid flow apparatus. The method may involve introducing into a first fluid flow module, via a plurality of inlet ports, a plurality of reactants comprising: at least one nucleoside triphosphate (NTP), a reaction buffer, and DNA, a DNA based compound or a DNA based mixture; allowing at least some of the reactants to react within a reaction channel or well within the first module of the flow system; retaining or recirculating the DNA at the first reactor module and allowing reaction products of the reactants to flow into a first fluidic filtration module; and filtering the reaction products within the first filtration module.